Amazon getting into cancer vaccines in partnership with Fred Hutchinson Cancer Center
jejim/iStock Editorial via Getty Images


Amazon.com (NASDAQ:AMZN) is taking arguably its most ambitious step into health care as it embarks on a research collaboration for a cancer vaccine with Seattle's Fred Hutchinson Cancer Center.
An entry on clinicaltrials.gov states that Fred Hutch is the sponsor and Amazon.com Services LLC is a collaborator. The arrangement was first reported by Business Insider.

A phase 1 trial is examining a personalized neo-antigen peptide vaccine for stage IIIC-IV melanoma or hormone receptor positive Her2-negative breast cancer that has metastasized or is refractory to other treatments.
This type of personalized vaccine "combines multiple patient specific neo-antigens," according to the listing.
The trial is taking place through the Fred Hutch/University of Washington Cancer Consortium.
In February, Amazon (AMZN) said it was rolling out nationwide its telehealth service, Amazon Care. The e-commerce giant also launched Amazon Pharmacy in 2020.